Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma

Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma

Aim. The purpose of this study was to examine the association of increasing concentrations of endothelin-1 and soluble forms of ST2 protein (sST2) in the blood plasma of patients with chronic heart failure (CHF) who underwent implantation of a cardioverter-defibrillator, with the development of car...

Full description

Bibliographic Details
Main Authors:	A. T. Teplyakov, N. I. Tarasov, L. K. Isakov, E. V. Grakova, M. N. Sinkova, K. V. Kopieva, О. B. Garmaeva, O. N. Ogurkova, V. V. Kalyuzhin, E. V. Kalyuzhina
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2018-09-01
Series:	Bûlleten' Sibirskoj Mediciny
Subjects:	chronic heart failure implantable cardioverter-defibrillator cardiovascular events prognosis biomarkers endothelin-1 soluble forms of st2 protein
Online Access:	https://bulletin.tomsk.ru/jour/article/view/1293

Similar Items

POSSIBILITY AND NECESSITY OF CATHETER ABLATION OF VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH ISCHEMIC HEART DISEASE AND IMPLANTED CARDIOVERTERDEFIBRILLATOR
by: G. A. Gromyko, et al.
Published: (2018-01-01)

Low QRS voltage and atrial fibrillation precluding implantation of a subcutaneous implantable cardioverterdefibrillator in a patient with arrhythmogenic cardiomyopathy
by: Peter C. Kahr, et al.
Published: (2017-12-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

A Single Shock During An Episode Of Ventricular Tachycardia: Is The Device Working Properly?
by: Jesus Jimenez-Lopez, MD, et al.
Published: (2012-09-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

High Defibrillation Threshold: The Science, Signs and Solutions
by: Sony Jacob, et al.
Published: (2010-01-01)

Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
by: Maciej Kempa, et al.
Published: (2021-07-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

Magnets and implantable cardioverter defibrillators: What′s the problem?
by: Yiliam F Rodriguez-Blanco, et al.
Published: (2013-01-01)

Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test
by: E. V. Grakova, et al.
Published: (2019-09-01)

THE ROLE OF ENDOTHELIN-1 IN VASCULAR HEMOSTASIS OF PERIODONTAL TISSUES
by: N.V. Yarychkivska
Published: (2017-03-01)

SMART pass will prevent inappropriate operation of S‐ICD
by: Motomi Tachibana, et al.
Published: (2019-02-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

Routine DFT testing in patients undergoing ICD implantation does not improve mortality: A systematic review and meta‐analysis
by: Munish Kannabhiran, et al.
Published: (2018-12-01)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
by: Naga VA Kommuri, et al.
Published: (2010-01-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
by: Ufuk Eryılmaz, et al.
Published: (2013-10-01)

Effectiveness of a flexible coiled sheath for correcting an acute angle between the brachiocephalic vein and the superior vena cava for successful defibrillator implantation
by: Yeon Pyo Yoo, et al.
Published: (2012-12-01)

Can machine learning complement traditional medical device surveillance? A case-study of dual-chamber implantable cardioverter–defibrillators
by: Ross JS, et al.
Published: (2017-08-01)

Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators
by: Ataallah Bagherzadeh, et al.
Published: (2006-04-01)

Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
by: John Fanourgiakis, et al.
Published: (2016-01-01)

Psychological Problems of Patients with Implantable Cardioverter Defibrillators in Baghdad City.
by: Bayda'a A. Kareem
Published: (2014-04-01)

OVERSENSING AS A CAUSE OF INAPPROPRIATE IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR THERAPY - CASE REPORT
by: Tomislav Kostić, et al.
Published: (2013-12-01)

Factors That Cause Concerns after Cardioverter Defibrillator Implantation
by: Olimpia Karczewska, et al.
Published: (2021-06-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Comparison of p38 MAPK, soluble endoglin and endothelin-1 level in severe preeclampsia and HELLP syndrome patients
by: Efendi Lukas, et al.
Published: (2019-01-01)

Hälsorelaterad livskvalitet hos patienter med implantable cardioverter defibrillator : En litteraturöversikt
by: Andersson, Kristoffer, et al.
Published: (2009)

Decline in physical activity in the weeks preceding sustained ventricular arrhythmia in women
by: Ashley E. Burch, PhD, et al.
Published: (2020-10-01)

Patienters livskvalité och erfarenheter av att leva med implanterbar cardioverterdefibrillator (ICD) : En litteraturstudie
by: Halin, Thomas, et al.
Published: (2015)

Unheralded failure of Riata defibrillator lead identified at defibrillation threshold testing
by: Matthew R. Webber, MB ChB, FRACP, et al.
Published: (2013-06-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Prognostic role of ST2 in patients with chronic heart failure of ischemic etiology and carbohydrate metabolism disorders
by: E V Grakova, et al.
Published: (2019-01-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

The VDD ICD lead: Friend or Foe?
by: Suneet Mittal, MD
Published: (2020-07-01)

Unusual fracture in a Durata lead with shock coil fragmentation and cable externalization
by: Toshiaki Sato, MD, et al.
Published: (2017-07-01)

Endothelins as mediators in the modulation of cardiac performance
by: Smiljić Sonja, et al.
Published: (2014-01-01)

Cannot write session to /tmp/vufind_sessions/sess_dil30368j1fkjdqc04770fral1